Name | Regency At Westland |
---|---|
Location | 2209 N Newburgh, Westland, Michigan |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 120 |
Occupancy Rate | 85.33% |
Medicare ID (CCN) | 235655 |
Legal Business Name | Camelot Hall Acquisition Company Inc |
Ownership Type | For Profit - Corporation |
NPI Number | 1891792032 |
Organization Name | CAMELOT HALL ACQUISITION COMPANY INC |
Doing Business As | CAMELOT HALL CONVALESCENT CENTER |
Address | 2209 N Newburgh Rd, Westland, MI 48185 |
Phone Number | 734-522-1444 |
News Archive
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.
Patients developing AFib after TAVR are at higher risk of death, stroke and heart attack compared to patients who already had AFib prior to the procedure, according to a study today in JACC: Cardiovascular Interventions. The paper is the first nationwide examination of patients who developed AFib for the first time following TAVR.
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
Transplanting fat may treat such inherited metabolic diseases as maple syrup urine disease (MSUD) by helping the body process the essential amino acids that these patients cannot, according to Penn State College of Medicine researchers.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.
Patients developing AFib after TAVR are at higher risk of death, stroke and heart attack compared to patients who already had AFib prior to the procedure, according to a study today in JACC: Cardiovascular Interventions. The paper is the first nationwide examination of patients who developed AFib for the first time following TAVR.
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
Transplanting fat may treat such inherited metabolic diseases as maple syrup urine disease (MSUD) by helping the body process the essential amino acids that these patients cannot, according to Penn State College of Medicine researchers.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 17.65 | 14.46 |
Percentage of long-stay residents who lose too much weight | 11.7 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.93 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.65 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.68 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.63 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.88 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 77.43 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 8.55 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 25.31 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.74 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 26.44 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.58 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 9.22 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 92.27 | 95.98 |
Percentage of short-stay residents who made improvements in function | 80.43 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 34.01 | 82.93 |
News Archive
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.
Patients developing AFib after TAVR are at higher risk of death, stroke and heart attack compared to patients who already had AFib prior to the procedure, according to a study today in JACC: Cardiovascular Interventions. The paper is the first nationwide examination of patients who developed AFib for the first time following TAVR.
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
Transplanting fat may treat such inherited metabolic diseases as maple syrup urine disease (MSUD) by helping the body process the essential amino acids that these patients cannot, according to Penn State College of Medicine researchers.
› Verified 6 days ago
Cherry Hill For Nursing And Rehabilitation Location: 38410 Cherry Hill Rd, Westland, Michigan 48185 Phone: (734) 326-1200 | |
Four Seasons Nursing Center Of Westland Location: 8365 Newburgh Rd, Westland, Michigan 48185 Phone: (734) 416-2000 | |